TY - JOUR
T1 - Understanding the mechanisms underlying pulsating aerosol delivery to the maxillary sinus: In vitro tests and computational simulations
AU - Si, Xiuhua April
AU - Xi, Jinxiang
AU - Lehman, Mark Edward
PY - 2017/2/9
Y1 - 2017/2/9
N2 - Background: Pulsating aerosol delivery has been demonstrated in depositing medications into paranasal
sinuses. However, its mechanisms are not fully understood. Influences of the nasal anatomy and sound
frequency on intrasinus delivery are not yet clear.
Objectives: This study aimed to gain a better understanding of the mechanisms for enhanced intrasinus
delivery with pulsating sound. Specifically, effects of the pulsation frequency, ostium size, and sinus
shape on the intrasinus dosage and resonance frequency would be examined.
Methods and materials: Both experiments and computational modeling were conducted to understand
the pulsating aerosol delivery in both idealized (two-bottle) and realistic nose-sinus models. A
computational model of intrasinus pulsation delivery was developed using COMSOL and was crossvalidated
with both experimental and theoretical results.
Results: In contrast to previous studies, seemingly erratic relations between the intrasinus dosage and
ostium diameter were observed in experiments, which suggested a more complicated particle transport
mechanism. Improved agreement was achieved when grouping the ostium size and sinus volume into
the resonance frequency, and therefore, validated the hypothesis that intrasinus deposition strongly
depends on the resonance frequency. Extensive computational simulations revealed that the deposition
was highest at the resonance frequency and decreased gradually at off-resonance frequencies. The
resonance frequency depended on the ostium and sinus morphology, but was independent of the nasal
cavity.
Conclusion: Results of this study verified the hypothesis of resonance being the mechanism for enhanced
particle deposition in the maxillary sinus. A better knowledge of the relationship between sinus dosages,
pulsating frequency, and nasal morphometry is essential for improving the design of intrasinus delivery
devices.
AB - Background: Pulsating aerosol delivery has been demonstrated in depositing medications into paranasal
sinuses. However, its mechanisms are not fully understood. Influences of the nasal anatomy and sound
frequency on intrasinus delivery are not yet clear.
Objectives: This study aimed to gain a better understanding of the mechanisms for enhanced intrasinus
delivery with pulsating sound. Specifically, effects of the pulsation frequency, ostium size, and sinus
shape on the intrasinus dosage and resonance frequency would be examined.
Methods and materials: Both experiments and computational modeling were conducted to understand
the pulsating aerosol delivery in both idealized (two-bottle) and realistic nose-sinus models. A
computational model of intrasinus pulsation delivery was developed using COMSOL and was crossvalidated
with both experimental and theoretical results.
Results: In contrast to previous studies, seemingly erratic relations between the intrasinus dosage and
ostium diameter were observed in experiments, which suggested a more complicated particle transport
mechanism. Improved agreement was achieved when grouping the ostium size and sinus volume into
the resonance frequency, and therefore, validated the hypothesis that intrasinus deposition strongly
depends on the resonance frequency. Extensive computational simulations revealed that the deposition
was highest at the resonance frequency and decreased gradually at off-resonance frequencies. The
resonance frequency depended on the ostium and sinus morphology, but was independent of the nasal
cavity.
Conclusion: Results of this study verified the hypothesis of resonance being the mechanism for enhanced
particle deposition in the maxillary sinus. A better knowledge of the relationship between sinus dosages,
pulsating frequency, and nasal morphometry is essential for improving the design of intrasinus delivery
devices.
UR - https://dx.doi.org/10.1016/j.ijpharm.2017.02.017
M3 - Article
SN - 0378-5173
VL - 520
SP - 254
EP - 266
JO - International Journal of Pharmaceutics
JF - International Journal of Pharmaceutics
ER -